Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: Graves' Disease Remission Study: MycoMeth Combo [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for MycoMeth Combo in Graves' disease currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MycoMeth Combo

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Graves' Disease | Phase 2, Phase 3 | Status: RECRUITING